Open AccessPalifermin-Associated Papular Eruption
Author(s) -
Brett King,
Eleanor Knopp,
Anjela Galan,
Gerard J. Nuovo,
Robert E. Tigelaar,
Jennifer M. McNiff
Publication year - 2009
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archdermatol.2008.548
Subject(s) - medicine , intertriginous , dermatology , erythema , pathology , skin biopsy , keratinocyte growth factor , biopsy , growth factor , receptor , disease
Palifermin is a recombinant human keratinocyte growth factor that is used to reduce the duration and severity of oral mucositis in patients undergoing hematopoietic stem cell transplantation after myelotoxic therapy. Cutaneous adverse reactions associated with keratinocyte growth factor are reported to be rash, pruritus, and erythema.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom